In 2023, AstraZeneca said it had decided not to build a new $400m drug factory in Britain because of its “discouraging” tax ...

AstraZeneca on Monday announced plans to invest $50 billion in its US operations by 2030, a sweeping commitment that includes ...

Astrazeneca said it will spend the huge sum over the next five years, including on a new manufacturing facility in Virginia, its largest-ever single manufacturing investment ...

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...

The move is the latest by a drugmaker as Trump threatens to impose import tariffs on the industry. Read more at ...

AstraZeneca Plc plans to invest $50 billion in the US before 2030, becoming the latest European pharma company to ratchet up ...

AstraZeneca CEO Sir Pascal Soriot explains the reasoning behind its $50 billion expansion of operations across the U.S.

The company said the Virginia facility "would be AstraZeneca’s largest single manufacturing investment in the world." The ...